Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-242321
Filing Date
2024-10-24
Accepted
2024-10-24 08:33:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d887400d424b3.htm 424B3 13015
2 GRAPHIC g887400g1023022628080.jpg GRAPHIC 3479
  Complete submission text file 0001193125-24-242321.txt   19155
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 241390828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)